Seth Lederman, Tonix Pharmaceuticals CEO
December 21, 2023 11:11 AM EST
Financing
R&D

Tonix rais­es $144M in a di­rect of­fer­ing fol­low­ing pos­i­tive PhI­II da­ta for its fi­bromyal­gia drug

Katherine Lewin

News Reporter

Tonix Phar­ma­ceu­ti­cals said it’s rais­ing $144 mil­lion in a di­rect of­fer­ing that in­cludes $30 mil­lion up­front on the same day that …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Bridge­Bio shares promis­ing re­sults in tri­al of Cana­van dis­ease gene ther­a­py

CRISPR ther­a­py re­duces swelling at­tacks by 81% in In­tel­lia fol­low-up study

Fac­ing lost re­bates, MGM Re­sorts to stop cov­er­ing GLP-1 weight loss shots

Ex­clu­sive: Uni­ver­si­ty of Toron­to spin­out rais­es $53.5M to cre­ate new obe­si­ty drugs with AI

Icon's quar­ter­ly earn­ings hit by biotech and phar­ma pull­back

sponsored

IDEAYA Bio­sciences: Tar­get­ing un­met mar­ket needs with pre­ci­sion on­col­o­gy

A service from the Financial Times